| 3.98 0.03 (0.76%) | 09-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 5.37  |
1-year : | 6.27 |
| Resists | First : | 4.59 |
Second : | 5.37 |
| Pivot price | 3.96 |
|||
| Supports | First : | 3.83 |
Second : | 3.35 |
| MAs | MA(5) : | 3.87 |
MA(20) : | 4.07 |
| MA(100) : | 4.12 |
MA(250) : | 3.66 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 46.3 |
D(3) : | 42.2 |
| RSI | RSI(14): 49.9 |
|||
| 52-week | High : | 6.71 | Low : | 1.11 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ABSI ] has closed below upper band by 48.5%. Bollinger Bands are 20.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.2 - 4.21 | 4.21 - 4.22 |
| Low: | 3.85 - 3.87 | 3.87 - 3.89 |
| Close: | 3.95 - 3.98 | 3.98 - 4 |
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Tue, 17 Sep 2024
Absci Co. (NASDAQ:ABSI) Short Interest Up 8.1% in August - MarketBeat
Mon, 19 Aug 2024
Absci Corporation (NASDAQ:ABSI) Q2 2024 Earnings Call Transcript - Insider Monkey
Wed, 14 Aug 2024
Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results - StockTitan
Wed, 14 Aug 2024
Absci Corporation (ABSI) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Mon, 12 Aug 2024
Absci Corporation Partners with Memorial Sloan Kettering to Advance AI-Driven Cancer Therapeutics - SynBioBeta
Wed, 31 Jul 2024
Why Is Absci Corporation (ABSI) Among the Best Micro Cap Stocks Right Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 114 (M) |
| Held by Insiders | 8.509e+007 (%) |
| Held by Institutions | 20.3 (%) |
| Shares Short | 10,870 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.396e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 104 % |
| Return on Equity (ttm) | -24 % |
| Qtrly Rev. Growth | 3.25e+006 % |
| Gross Profit (p.s.) | -28.07 |
| Sales Per Share | -19.03 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -60 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | -0.2 |
| Price to Book value | 0 |
| Price to Sales | -0.21 |
| Price to Cash Flow | 4.53 |
| Dividend | 0 |
| Forward Dividend | 1.208e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|